These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 37515745)

  • 1. The Exploration of Cannabis and Cannabinoid Therapies for Migraine.
    Chandwani B; Bradley BA; Pace A; Buse DC; Singh R; Kuruvilla D
    Curr Pain Headache Rep; 2023 Sep; 27(9):339-350. PubMed ID: 37515745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Baron EP
    Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
    Baron EP; Lucas P; Eades J; Hogue O
    J Headache Pain; 2018 May; 19(1):37. PubMed ID: 29797104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and Migraine: It's Complicated.
    Mechtler LL; Gengo FM; Bargnes VH
    Curr Pain Headache Rep; 2021 Feb; 25(3):16. PubMed ID: 33630181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids: for better and for worse
.
    Thibaut F; Hoehe MR
    Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey.
    Melinyshyn AN; Amoozegar F
    Can J Neurol Sci; 2022 Nov; 49(6):781-790. PubMed ID: 34511153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Cannabis for Headache Pain: a Primer for Clinicians.
    Duarte RA; Dahmer S; Sanguinetti SY; Forde G; Duarte DP; Kobak LF
    Curr Pain Headache Rep; 2021 Oct; 25(10):64. PubMed ID: 34628531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol.
    Chhabra M; Lewis EC; Balshaw R; Stewart B; Zaslawski Z; Lowthian T; Alidina Z; Chesick-Gordis M; Xie W; Drögemöller BI; Wright GEB; Birnie KA; Boerner KE; Tsang VWL; Irwin SL; Pohl D; Weil AG; Sell E; Penz E; Robson-MacKay A; Mbabaali S; Blackman S; Gordon S; Alcorn J; Huntsman RJ; Oberlander TF; Finley GA; Kelly LE
    PLoS One; 2024; 19(9):e0290185. PubMed ID: 39302982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.